HomeCLDX • NASDAQ
Celldex Therapeutics Inc
add
$20.45
1.74%
After Hours:(0.00%)0.00
$20.45
Closed: May 16, 4:30:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 695.00K | 345.51% |
Operating expense | 10.82M | 18.86% |
Net income | -53.80M | -63.97% |
Net profit margin | -7.74K | 63.19% |
Earnings per share | -0.81 | -44.64% |
EBITDA | -61.87M | -55.33% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 673.29M | -18.27% |
Total assets | 739.47M | -14.89% |
Total liabilities | 36.49M | 20.69% |
Total equity | 702.98M | — |
Shares outstanding | 66.39M | — |
Price to book | 1.90 | — |
Return on assets | -20.48% | — |
Return on capital | -21.53% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -53.80M | -63.97% |
Cash from operations | -54.37M | -33.80% |
Cash from investing | 42.95M | 113.63% |
Cash from financing | 202.00K | -99.95% |
Net change in cash | -11.22M | -113.98% |
Free cash flow | -35.41M | -36.23% |
Previous close
$20.10
Day range
$19.84 - $20.69
Year range
$14.40 - $47.00
Market cap
1.36B USD
Avg Volume
799.41K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1983
Headquarters
Website
Employees
186
